Linking Circulating One-Carbon Metabolism Biomarkers to Glymphatic System Activity

Overview

This study investigates the relationship between one-carbon metabolism (OCM) biomarkers and glymphatic function in Alzheimer's disease (AD), revealing that lower serum folate levels and reduced glymphatic activity correlate with poorer cognitive performance. The findings suggest a potential interrelationship that warrants further exploration in longitudinal studies.

Background

Alzheimer's disease (AD) is a leading cause of dementia, with a significant increase in prevalence over recent decades. Understanding the underlying mechanisms, including the roles of one-carbon metabolism and the glymphatic system, is crucial for developing early interventions. This research highlights the importance of serum nutritional biomarkers in the context of cognitive decline associated with AD.

Data Highlights

Key Findings

• Significant differences in serum folate levels and DTI-ALPS index between normal cognition and AD groups.
• Positive correlation between serum folate levels and DTI-ALPS index in AD patients.
• Low-risk group (high folate and high DTI-ALPS index) showed better cognitive performance than high-risk group.
• Lower serum folate and reduced DTI-ALPS index linked to poorer cognitive outcomes in AD.
• Findings suggest a potential association between metabolic status and glymphatic function in AD.

Clinical Implications

Clinicians should consider monitoring serum folate levels and glymphatic function in patients with Alzheimer's disease, as these factors may influence cognitive outcomes. Early interventions targeting nutritional status could be beneficial in managing cognitive decline.

Conclusion

The study underscores the importance of one-carbon metabolism and glymphatic function in Alzheimer's disease, suggesting that their interplay may be critical for cognitive health. Further research is needed to confirm these findings and explore their implications for clinical practice.

Related Resources & Content

1. BMC Psychiatry, 2025 -- Glymphatic alteration in NAFLD patient: a preliminary magnetic resonance imaging study based on DTI-ALPS
2. conexiant -- A Two-Biomarker Signal for Alzheimer’s Disease
3. Acta Neuropathologica, 2025 -- Unique cerebrovascular mechanisms contributing to neurodegeneration in Alzheimer's disease
4. Acta Neuropathologica -- Plasma Biomarkers Associated with Alzheimer’s Disease: Links to Neuropathological Changes and Cognitive Decline
5. Criteria for Diagnosis and Staging of Alzheimer's Disease | alz.org
6. Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis | Nutrition Reviews
7. Diffusion Tensor Imaging along the Perivascular Space for Characterizing Cerebral Interstitial Fluid Dynamics in Alzheimer Disease: A Systematic Review and Meta-Analysis - PubMed
8. Criteria for Diagnosis and Staging of Alzheimer's Disease | alz.org
9. Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis | Nutrition Reviews | Oxford Academic
10. Diffusion Tensor Imaging along the Perivascular Space for Characterizing Cerebral Interstitial Fluid Dynamics in Alzheimer Disease: A Systematic Review and Meta-Analysis - PubMed